The first treatments making use of Crispr gene editing may suffer some early hiccups
When it was announced in 2023 that the world’s first Crispr-based gene-editing therapy had been approved in the UK there was much excitement. After all, it was a mere three years since the development of this gene-editing tool was recognised with the Nobel prize in chemistry. It went from lab tool to the clinic to market in record time.